Ann: Half Yearly Report and Accounts, page-2

  1. 5,930 Posts.
    lightbulb Created with Sketch. 889
    Mmm so there is 4.5 mill left so CR not needed next week...

    As reported on 7 September 2020, several compounds have been shown in laboratory cell-culture studies to have antiviral activity against SARS-CoV-2. The assays were run under contract by an Australian NATA accredited clinical trial speciality laboratory, 360biolabs, based in Melbourne, Victoria. Since September 2020 the Company has expanded its screening program to include a new series of recently designed and synthesised compounds.

    These additional new compounds are progressing through a panel of cell-based screening assays which are designed to identify the most potent, druggable compound(s) in the series. The screening is progressing well and it is anticipated that a subset will soon be identified for progression to an animal model of the Covid-19 disease."

    It will be a miracle, but they do happen...IMO
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $3.318M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.213K 485K

Buyers (Bids)

No. Vol. Price($)
48 38814169 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 15608555 20
View Market Depth
Last trade - 13.43pm 01/08/2025 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.